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Background: Patients who are hospitalized with a first or recurrent stroke often are discharged with new
medications or adjustment to the doses of pre-admission medications, which can be confusing and pose safety
issues if misunderstood. The purpose of this pilot study was to assess the feasibility of medication coaching via
telephone after discharge in patients with stroke.
Methods: Two-arm pilot study of a medication coaching program with 30 patients (20 intervention, 10 control).
Consecutive patients admitted with stroke or TIA with at least 2 medications changed between admission and
discharge were included. The medication coach contacted intervention arm patients post-discharge via phone call
to discuss risk factors, review medications and triage patients’ questions to a stroke nurse and/or pharmacist.
Intervention and control participants were contacted at 3 months for outcomes. The main outcomes were
feasibility (appropriateness of script, ability to reach participants, and provide requested information) and participant
evaluation of medication coaching.
Results: The median lengths of the coaching and follow-up calls with requested answers to these questions were
27 minutes and 12 minutes, respectively, and participant evaluations of the coaching were positive. The
intervention participants were more likely to have seen their primary care provider than were control participants
by 3 months post discharge.
Conclusions: This medication coaching study executed early after discharge demonstrated feasibility of coaching
and educating stroke patients with a trained coach. Results from our small pilot showed a possible trend towards
improved appointment-keeping with primary care providers in those who received coaching.
Keywords: Stroke, Transitions, Prevention, Patient educationBackground
Stroke is a common and devastating disease that affects
almost 800,000 people in the US each year and is a lead-
ing cause of serious long-term disability [1]. Approxi-
mately 610,000 of these strokes are first attacks, and
185,000 are recurrent attacks [1]. The transition to home
after an acute stroke hospitalization requires that
patients make substantial adjustments to learn how to
cope with their condition, their medications and, poten-
tially, new disabilities within a short timeframe. Early
supported discharge for stroke patients shows promise* Correspondence: cbushnel@wakehealth.edu
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reproduction in any medium, provided the ortowards facilitating the transition from hospital to home,
although this approach is more commonly utilized in
Europe [2]. Frequently, however, stroke survivors and
their caregivers are unprepared for this new role: they
may not know the patient’s discharge diagnosis, may
have difficulty understanding complex medication regi-
mens and be unsure who to contact with questions about
their condition or prescribed medications [3-5]. As
expected, patients have reported dissatisfaction with the
quality and quantity of information provided by health
professionals during their hospital stay [6].
The kind of information required by patients varies
depending upon the care setting and their health care
needs [7-9]. In-depth qualitative interviews of stroke
patients found that in the first month post-discharge,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of their stroke and prevention of recurrence; the signifi-
cance of symptoms and how they should be managed;
and information on medications, such as how to obtain
refills or even if refills are needed [6]. The provision of
information, tools and structured support in the transi-
tion to home has been shown to improve patients’
understanding of their diagnoses and medications, in-
crease patients’ confidence in their ability to manage
their condition, decrease patient anxiety, improve health
outcomes and reduce hospital re-admissions [3,5,7,9-15].
Key elements of effective care transitions include as-
sistance with managing medications; written material
that includes critical medical information and a list of
the patient’s medications, information on warning signs
and adverse events and instructions on how they
should be managed, including who to contact; and en-
couragement to follow-up with primary or specialty
care in a timely manner [5,6,10,16]. One study demon-
strated that patient counseling with a single phone call
shortly after hospital discharge resulted in a statistically
significant decrease in preventable adverse drug events
and significantly higher satisfaction with medication
instruction [17].
Our goal is the development of a program to support
patients in their transition to home after hospitalization
for stroke or transient ischemic attack (TIA). We designed
a pilot study to evaluate and refine a medication coaching
program before it was implemented as hospital-wide
standard of care. The objectives were: a) assess the feasi-
bility of the intervention in terms of the appropriateness
of script, ability to reach participants, and provide the
requested information, and b) to assess the preliminary
impact of the intervention on medication knowledge,
medication persistence, and appointment-keeping.
Methods
Design overview
We performed a two-arm pilot study of 30 patients at
Wake Forest Baptist Medical Center (WFBMC) admitted
with ischemic or hemorrhagic stroke or TIA who had at
least 2 medications changed between admission and dis-
charge and who were discharged home. Figure 1 pro-
vides an overview of the study design.
With daily review of all neurology hospital admissions,
consecutive, potential participants who met the eligibility
criteria were visited by the study coordinator who ex-
plained the study and reviewed the consent form. Each
subject who agreed to participate signed a consent form.
They were also asked to provide a phone number where
they could be reached once they were released from hos-
pital as well as that of a close friend or relative who
would be familiar with their whereabouts. The study was
approved by the Institutional Review Board of both thestudy institution and the data coordinating center (Duke
Clinical Research Institute) prior to the enrollment of
subjects. Figure 2 shows the flow from screening to
follow-up.
Study procedures
Prior to hospital discharge, all participants received an
information packet containing materials on when to call
911 or their physician and/or pharmacist; general life-
style information for stroke prevention; a check list of
their personal risk factors and additional information
about each; and a list of their current medications, what
they were for and dosage. The medication coach re-
viewed the contents of the packet with each participant
prior to discharge.
The first 20 participants were intended to receive the
intervention, which consisted of a telephone contact
from a medication coach within the first 2 weeks after
discharge and included general information about
stroke, the importance of preventing another stroke,
modifiable risk factors and the importance of adhering
to prescribed medications. In addition, the medication
coach reviewed each stroke prevention medication on
the participant’s discharge list and asked whether he or
she was still taking the medication, and if not, why not.
Finally, the coach assessed the participant’s understand-
ing of each medication’s purpose, how to take it, refill it,
and its side effects. Participants were also asked if they
had any specific questions about their medications or
stroke recovery. The coach triaged medication-related
questions to a pharmacist and stroke-related questions
to a stroke nurse, then compiled responses from these
clinicians, and called the subject back with the informa-
tion. Compiled responses were also summarized in writ-
ten form and sent to the participant’s primary care
provider with a cover letter explaining the patient’s par-
ticipation in the program. Detailed or lengthy answers to
participants’ questions were summarized on a 7th grade
reading level and sent to each participant in a follow-up
letter from the medication coach.
Participants in the control arm (n = 10) were not called
by the medication coach. All participants were contacted
at 3 months to assess medication use, appointment
keeping, functional status, and resource utilization.
Coaching script development
The medication coaching script and the discharge packet
information were written at a 7th grade reading level.
The first two participants had their 2-week medication
coaching session as an in-person interview during which
they also provided feedback on the process. The next 3
participants were contacted via telephone for the coach-
ing call and they also gave feedback. To aid in the devel-
opment of the medication coaching “script,” these first 5
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Figure 1 The medication coaching study design.
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of the interaction and the information provided with a
staff member from the data coordinating center via tele-
phone. After the initial 5 interviews were completed, the
study team made final revisions to the study forms and
scripts. The next 15 participants were contacted via tele-
phone approximately 2 weeks after hospital discharge
for their interviews using the revised script and forms.
The intervention was designed to be supplemental to
the care, education and information provided by the
stroke unit physicians, nurses and other medical staff
members.
Data collection
Baseline data were obtained from a combination of
medical record review and participant interview prior
to discharge and included: pre-admission stroke pre-
vention medications; history of stroke risk factors; fam-
ily history of stroke; NIHSS on admission; functionalstatus; demographic and socioeconomic information; spe-
cific diagnosis; hospital course; laboratory values; percep-
tion of patient-provider communication; patient ability
to care for self; perception of health status (EuroQOL-
5-D or EQ-5D)[18]; depression status (Patient Health
Questionnaire-8 or PHQ-8)[19]; complications and dis-
charge stroke prevention medications.
Interviewers from the data coordinating center con-
ducted the 3-month telephone interviews (not the
medication coach), and asked about current stroke pre-
vention medications; medications that were stopped
and reason for stoppage; functional status; demo-
graphic and socioeconomic information; current smok-
ing status; Care Transitions Measure (CTM-3) [20];
patient-provider communication; patient’s ability to
care for self; medication tracking/assistance; patient
satisfaction with hospital treatment, care and informa-
tion provided; perceived burden of medical costs;
health insurance status; current status of stroke/stroke
Assessed for eligibility (n=34) 
Excluded (n=2) 
 Declined to participate (n=2) 
Intervention (n=17)  
First 10 subjects also have proxy 
respond to questionnaire 
Patients withdrew participation (n=2)   
Intervention Arm (n=20);  
 Received intervention (n=19) 
 Lost to follow-up prior to intervention (n=1) 
Control arm (n=8)  
First 5 subjects also have proxy 
respond to questionnaire 
Patients lost to follow-up (n=2) 
  









 Did not meet eligibility 
critieria—not discharged home 
(n=2) 
Figure 2 Flow diagram of study enrollment, group assignment, and follow-up at 3 months.
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perception of health state (EQ-5D); depression status
(PHQ-8); hospitalizations and ED visits since discharge;
and post-discharge rehabilitation utilization.
In addition to the 3-month participant interviews, for
10 of the 20 intervention group participants and 5 of the
10 control group participants, interviews were con-
ducted with a proxy designated by the participant at the
initial hospital interview. Proxy interviews enabled us to
collect follow-up data on 4 participants we were unable
to contact and all proxies provided additional informa-
tion related to medication persistence and participants’
status at 3 months.
Data analysis
The primary outcomes of this pilot study are: 1) feasibil-
ity of the intervention (ability to reach participants,
number of attempts, and time spent on the telephone),
and 2) participants’ evaluation of the medication coach-
ing script and its implementation.
The secondary outcomes are: 1) impact of intervention
on medication persistence, knowledge, and appointment-
keeping; 2) clinical and functional outcomes (including
depression) at 3 months, and 3) resource utilization (re-
hospitalizations and Emergency Department visits) at
3 months.Descriptive statistics included counts with percentages
for discrete variables and medians with interquartile
ranges for continuous variables. Comparisons were per-
formed according to treatment assignments (interven-
tion arm versus control arm).
We compared overall persistence between groups as
an all or none variable (i.e., subjects who remained on
all discharge medication classes at the 3-month follow-
up were considered persistent), whereas subjects who
stopped at least one class of medication prescribed at
discharge were “non-persistent” overall regardless of the
reason for stopping a medication. We also summarized
persistence at the class level.
Results
Of 32 enrolled participants, two patients were ineligible
because they were not discharged to home. One inter-
vention patient was never reached to perform the medi-
cation coaching and was unavailable for follow-up; thus,
there were 19 patients in the intervention group and 10
in the control group. Characteristics in the two groups
were similar, although those in the control arm were
more likely to be white, to be slightly younger and to re-
port having health insurance (Table 1). A greater per-
centage of subjects in the intervention arm had a stroke
as opposed to aTIA. Intervention subjects were discharged
Table 1 Baseline Characteristics of Enrolled Subjects
Characteristics Overall (n = 29) Intervention Arm (n = 19) Control Arm (n = 10)
Female 12 (41.4 %) 8 (42.1 %) 4 (40.0 %)
Median age (IQR) 61 (52–69) 61(55–70) 59 (47–67)
Race
African American 13 (44.8) 10 (52.6) 3 (30)
White 16 (55.2) 9 (47.4) 7 (70)
NIHSS, median (IQR) 1(1–3) 2 (1–4) 1 (1–2)
Stroke type
Ischemic stroke 24 (82.2) 17 (89.5) 7 (70.0)
TIA 4 (13.8) 2 (10.5) 2 (20.0)
ICH 1 (3.5) 0 1 (10.0)
Medical history (or risk factors)
Prior stroke/TIA 10 (34.5) 7 (36.8) 3 (30.0)
Hypertension 22 (75.9) 16 (84.2) 6 (60.0)
Hyperlipidemia 20 (71.4) 14 (73.7) 6 (66.7)
Smoker 14 (48.3) 8 (42.1) 6 (60.0)
Diabetes 6 (20.7) 3 (15.8) 3 (30.0)
Atrial fibrillation 3 (10.3) 2 (10.5) 1 (10.0)
Number of discharge meds,
median (IQR)
4 (3–6) 5 (3–6) 4 (2–6)
Health Insurance
Yes 21 (72.4) 13 (68.4) 8 (80)
No 8 (27.6) 6 (31.6) 2 (20)
Health Insurance Type
Public 7 (33.3) 4 (30.8) 3 (37.5)
Private 9 (42.9) 6 (46.2) 3 (37.5)
Public and private 5 (23.8) 3 (23.1) 2 (25.0)
Income meets basic needs
More than adequately 4 (14.3) 3 (15.8) 1 (10.0)
Adequately 7 (25.0) 6 (31.6) 1 (10.0)
Somewhat 12 (42.9) 7 (36.8) 5 (50.0)
Not at all 5 (17.9) 3 (15.6) 2 (20.0)
Missing 1 (3.5) 0 1 (10.0)
IQR = interquartile range; NIHSS =National Institutes of Health Stroke Scale; TIA = transient ischemic attack; ICH = intracerebral hemorrhage; PCP = primary care
provider.
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ondary prevention medications (median = 5 medications
vs control median = 4).
Medication coaching script refinements and evaluations
After the first patient, concerns were raised regarding
the validity of using only yes/no responses when asking
if patients understand their medications. For better as-
sessment of participant competence and understanding,
the questions were changed to an open-ended format.
This change also enabled more appropriate teaching
moments during the call. Evaluations from the first 5participants regarding the medication coaching tele-
phone calls were favorable (Table 2).
Assessment of medication knowledge during
coaching calls
During the medication coaching contact, 7 out of 19
intervention group participants were able to identify
why they were taking all of their medications and an
additional 9 could state the reason for taking 50% or
more of their medications. Likewise, most could explain
how to refill their medications. However, none could
identify one side effect for all prescribed medications
Table 2 Evaluation of medication coaching intervention (first 5 participants)
Strongly Agree Agree Comments
Information we provided about stroke was
helpful to you.
40% 60% ‘wanted information on what to expect in
future,’ ‘more about prevention’
Information we provided about your
medications was helpful to you.
60% 40% ‘explained purpose of medications and side
effects’
Contact was an appropriate length. 80% 20%
Interviewer talked in a way that was easily
understood.
100%
If you requested additional information, were
your questions answered to your satisfaction
when you were called back?
100% (n = 3)
Other information that would be useful now
that you’re home recovering from your stroke?
‘stress prevention and nutrition,’ ‘covered
everything I could think to ask’
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participants taking warfarin (n =4) were able to identify
at least one side effect and knew that they required regu-
lar blood tests to determine its effectiveness.
The types of questions that were asked during the
coaching intervention call were similar among the inter-
vention participants, and frequently concerned why the
stroke occurred even while taking prevention medica-
tions, and how to prevent another stroke. One 57 year-
old participant asked why he was still having fatigue
after the stroke and whether it was due to his medica-
tions. The pharmacist’s response was that this was quite
possibly due to low blood pressure, and suggested the
patient take one of his three blood pressure medicationsTable 3 Three month outcomes for intervention and control p
Characteristics Overall (n = 26) I
Has method for tracking medications, N (%) 18 (69.2) 1
Understand how to take medications, N (%) 26 (100.0) 1
Understand why taking medications, N (%) 26 (100.0) 1
Understand side effects, N (%) 16 (61.5) 1
Know who to call if run out of meds, N (%) 26 (100.0) 1
Know what to expect with your health/illness
in the future, N (%)
19 (73.1) 1
Know what to do if problems/symptoms
continued or worsened, N (%)
22 (88.0) 1
Appointment with PCP since stroke, N (%) 21 (80.8) 1
PHQ-8 at 3 months, median (IQR) 8 (3.0-13.0) 5
EQ5D at 3 months, median (IQR) 0.8 (0.64-0.87) 0
Modified Rankin score, median (IQR) 2.0 (1.0-3.0) 1
CTM-3, median (IQR) 83.3 (77.8-100.0) 7
Re-hospitalization, N (%) 1 (4.2) 0
ED visit, N (%) 2 (8.7) 2
** Wilcoxon rank-sum test for continuous variables; Fisher’s exact test for categorica
PCP = Primary care provider; PHQ-8 = Patient Health Questionnaire-8; IQR= Interqua
ED= Emergency Department.at bedtime and the other two in the morning to see if
this helps the fatigue.
Follow-up calls and logistics
Fourteen of the 19 intervention patients required more
than one phone call to conduct the coaching intervention,
even within the two weeks after discharge. The median
number of calls required to complete the medication
coaching call was 2 (range 1–9). The median lengths of the
coaching and follow-up calls with requested answers to
questions were 27minutes and 12minutes, respectively.
Four participants out of 29 could not be contacted for
the 3-month interview, even after multiple attempts. Be-
cause of the difficulty in reaching patients and proxies,articipants
ntervention Arm (n= 16) Control Arm (n = 10) p-value**
1 (68.8) 7 (70.0) 1.000
6 (100.0) 10 (100.0) N/A
6 (100.0) 10 (100.0) N/A
0 (62.5) 6 (60.0) 1.000
6 (100.0) 10 (100.0) N/A
2 (75.0) 7 (70.0) 1.000
5 (93.8) 7 (77.8) 0.530
5 (93.8) 6 (60.0) 0.055
.50 (0.5-10.5) 10.5 (7.0-21.0) 0.080
.80 (0.69-0.94) 0.68 (0.59-0.87) 0.326
.50 (1.0-3.0) 2.50 (1.0-3.0) 0.531
7.8 (72.2-100.0) 88.9 (77.8-100.0) 0.640
(0) 1 (10.0) 0.333
(12.5) 0 (0) 1.000
l variables.
rtile range; EQ5D= EuroQOL-5-D; CTM-3 = Care Transition Measure-3;
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the 3 month target time window. The reasons for not
reaching patients included: disconnected numbers,
people out of country/out of state, and 2 patients were
living with various relatives and moving frequently. For
2 other patients in the control arm, interviewers were
only able to interview the proxy and not the patient.
The number of attempts made to reach an individual
patient or proxy for their 3-month follow-up interview
ranged from 1 to 30, and there were no differences be-
tween intervention and control participants. We were
unable to collect 3-month follow-up information for 2
participants from the intervention arm (10.3% lost-to-
follow-up but proxy data were obtained).
Three month outcomes
For those successfully contacted at 3 months and able to
provide self-reported outcomes, we found little differ-
ence between the two groups in reported levels of know-
ledge or understanding about medications or stroke
(Table 3). More of the intervention participants knew
what to do if problems or symptoms continued or wor-
sened (93.8%) compared to controls (77.8%). A larger
proportion of intervention participants had seen their
primary care provider between discharge and 3 months
than those in the control group (93.8% vs. 60% in the
controls; p = 0.055). In addition, we found trends to-
wards lower depression (PHQ-8) severity scores in the
intervention group (median = 5.50 vs. 10.5 in controls;
p = 0.080), higher reported health status (EQ-5D) scores
(median 0.80 vs. 0.68), and lesser disability (mRS =1.5 in
cases vs. 2.5 among controls.)
Overall persistence with discharge medication regi-
mens was 88% (22 of 26), and was similar in both groups
(intervention 87.5% and control 88.9%). By medication
class, persistence was also high, ranging from 83% for
warfarin, 95% for antihypertensives and lipid-lowering
medications, and 100% for antiplatelet therapy and dia-
betes medications.
Discussion and conclusion
In this study, we pilot-tested and refined a medication
coaching script, assessed content validity of the script
and questionnaires, and obtained participants’ evaluation
of the intervention. We determined that this approach
was feasible, and participants expressed a high degree of
satisfaction with the information provided by the coach.
The medication coaching calls were designed to assess
medication knowledge of medications and triage individ-
ual questions about medications and the participant’s
stroke, per the script. The burden of attempted contacts
was reasonable, with a median number of 2 calls to
reach members of the intervention group. The 3-month
follow-up calls were more challenging because patientsmoved, changed phone numbers, and experienced major
life changes associated with having a stroke. Calling at
different times of day often was the key to reaching par-
ticipants. Other helpful procedures were to determine
whether the phone number provided at enrollment is for
a pre-paid cell phone and to obtain multiple phone num
bers for other relatives when possible. Most importantly,
contacting patients and/or proxies requires persistent
efforts.
Using a telephone intervention was practical for our
stroke population because patients treated at our institu-
tion reside in a wide geographic area, making home visits
restrictive. Telephone interventions have been used for
post-discharge interventions for medication management
in multiple settings. For example, patients discharged
from a general medical service received a follow-up
phone call by a pharmacist 2 days after discharge [17].
Patients randomized to the intervention (n = 110; con-
trols n = 111) were significantly more satisfied with dis-
charge instructions, had medication-related problems
solved during the intervention, and had fewer Emer-
gency Department visits (10% vs. 24% in the controls)
[17]. A study of 123 patients over age 50 with varying
underlying diseases utilized pharmacist follow-up for
medication management and found that the intervention
led to significantly greater resolution of medication and
health-related problems than the control group [21]. Ra-
ther than having pharmacists make the calls (as in the
above examples), we had a coach who could triage ques-
tions to the pharmacist or stroke nurse and supply their
answers to the participants. The pharmacist and nurse
provided personalized information that could be put in
writing for the patient and the primary care provider to
keep as a reference. We believe using a coach rather than
a pharmacist or nurse for calls may be more economical,
although we have not assessed cost-effectiveness in this
small study.
Medication non-persistence is associated with poorer
outcomes, greater likelihood of re-hospitalization and
increased mortality [22,23]. Although this study was not
designed to show an effect on medication persistence
due to the emphasis on feasibility and refinement of the
medication coaching script, medication persistence was
excellent in this small study. The Preventing Recurrence
of Thromboembolic Events through Coordinated Treat-
ment (PROTECT) program, which included multiple
materials for patients at discharge and contact by study
nurses 2 to 4 weeks after discharge, showed excellent
persistence of antiplatelet therapies, statins, and blood
pressure medications in stroke patients at 3 months
[24]. Similarly, a pharmacist call for a small cohort of
Medicare beneficiaries in Texas showed that persistence
with medications was not significantly improved, al-
though the intervention was associated with other
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and health related questions [21]. The feasibility of
medication coaching is currently being tested in
Scotland in a randomized controlled trial of 60 patients
with stroke to determine the impact on medication ad-
herence [25].
We also examined the impact of early post-discharge
medication coaching on medication knowledge and ad-
herence to follow-up appointments. Knowledge related
to why medications are taken, how to refill them, and
what to do if stroke symptoms recur was excellent in
both groups (Table 3), perhaps because of the educa-
tional materials all participants received. However, we
found that participants in the intervention group were
more likely to keep their primary care provider appoint-
ments (93.8%) than those in the control group (60%). A
key role of the coach is encouraging patients and care-
givers to keep medical appointments which is important
for preventing hospital readmissions [5], and reducing
the risk of stroke and death, especially in patients with
hypertension [26].
Short hospital stays following a transient ischemic at-
tack or stroke make in-hospital visits for educating pa-
tients about risk factors, medications and post-discharge
self-care a challenge. A call from a trained coach just
after discharge, when patients are reorienting themselves
to home, can provide answers to questions about their
stroke and their medications that they may not have
thought of during their stay. The coach can also re-
inforce the crucial messages for prevention of recurrent
stroke provided by hospital staff and the transition coach
prior to discharge.
Our pilot study was limited because these patients
were younger than the average stroke patient, and only
those discharged home were enrolled, which limits gen-
eralizability. As such, these patients had relatively mild,
i.e. non-disabling strokes (Table 1), but these are also the
patients who may gain the most from targeted interven-
tions to improve adherence to secondary prevention. We
included patients with TIAs in the intervention as well,
because these patients have a similar risk of recurrent
stroke, and guideline recommendations are the same for
both stroke and TIA [27]. Other limitations are the non-
random allocation of the intervention and the modifi-
cation of medication coaching script based on patient
feedback. Thus, the script in its final form was adminis-
tered to 14 of the 19 participants in the intervention
group. Most importantly, the small cohort size limits
conclusions regarding 3-month outcomes.
Conclusions
This pilot study demonstrates that educating stroke pa-
tients using pharmacy and nurse consultation, via a
trained coach represents a feasible and potentially vitaltool in early supported discharge after stroke. Contacting
patients by phone soon after discharge is a convenient
and relatively inexpensive way to provide assistance to
patients and caregivers. Larger studies will help deter-
mine the full impact and cost-effectiveness of this inter-
vention on medication persistence and other outcomes,
such as readmissions andpotentially avoidable admissions.
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